Group One Trading, L.P. Rhythm Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 4,991 shares of RYTM stock, worth $274,505. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,991
Previous 4,275
16.75%
Holding current value
$274,505
Previous $185,000
10.27%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding RYTM
# of Institutions
178Shares Held
69.1MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$402 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$371 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$352 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$335 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$291 Million0.04% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.06B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...